Healthcare Innovation March 17, 2023
David Raths

‘Culmination Bio was built to expand on the success of Intermountain’s precision medicine efforts by creating longitudinal multi-modal data sets,’ says Lincoln Nadauld, M.D., Ph.D., CEO of the new company

Utah-based Intermountain Health has launched a biotech company that it says is creating a platform of de-identified data to develop novel clinical insights, discoveries, and care processes.

Culmination Bio says its multi-modal intelligence platform provides its customers with access to omics-level data and an insights engine for medical research, health data, and healthcare services. Real-world data and evidence generation tied to the performance of diagnostics and therapeutics is a core component of the Culmination intelligence database.

Culmination launched its platform with the help of Intermountain Ventures, the strategic investment arm...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Health System / Hospital, Pharma / Biotech, Precision Medicine, Provider
Estonian Biobank to Sequence 10,000 Genomes as Part of Precision Medicine Project
Precision Immune Start-Up Mirador Launches with $400M+
The future of companion diagnostic (CDx) development: Why commercialization is key
STAT+: Drug development was once a marathon. New tools and timelines are turning it into a sprint
Precision Medicine Startup Mirador Unveils $400M for R&D of New I&I Drugs

Share This Article